Results 1 to 10 of about 917,276 (359)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer: Current Use and Future Prospects. [PDF]

Int J Mol Sci
Dickerson H, Diab A, Al Musaimi O.
europepmc   +1 more source

Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation. [PDF]

Curr Issues Mol Biol
Kim J, Joo JH, Kim J, Rim H, Shin JY, Choi YH, Min K, Lee SY, Jun SH, Kang NG.   +9 more
europepmc   +1 more source

Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression [Retraction]. [PDF]

Onco Targets Ther
europepmc   +1 more source

Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy. [PDF]

Med Drug Discov
Kumar R, Goel H, Solanki R, Rawat L, Tabasum S, Tanwar P, Pal S, Sabarwal A.   +7 more
europepmc   +1 more source

Receptor Tyrosine Kinase Signaling Involves Echinococcus-Host Intercommunication: A Potential Therapeutic Target in Hepatic Echinococcosis. [PDF]

Trop Med Infect Dis
Gao H, Bianba Z, Mo X, Hu W, Feng Z, Zhou F, Zhang T.   +6 more
europepmc   +1 more source

Protein tyrosine phosphatase PTPH1 potentiates receptor tyrosine kinase HER2 oncogenesis via a PDZ-coupled and phosphorylation-driven scaffold. [PDF]

Am J Cancer Res
Qi X, Wang F, Thomas L, Ma S, Palen K, Lu Y, Sheinin Y, Gershan J, Fu L, Chen G.   +9 more
europepmc   +1 more source

Alternating Administration of Osimertinib for Leptomeningitis and Docetaxel Plus Ramucirumab for Lung Adenocarcinoma Resistant to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. [PDF]

Intern Med
Tomizawa H, Mouri A, Mikoshiba S, Tsukamoto K, Abe Y, Oda M, Tsuchiya M, Yamana T, Suhara K, Kamimura M.   +9 more
europepmc   +1 more source